MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and… Oct 27, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Oct 26, 2021
Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow… Oct 26, 2021
British MP Pushes For Rescheduling Of Psilocybin (Plus 3 Psychedelic PubCos Working In The UK) Oct 22, 2021
Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder Oct 21, 2021
